Callan Family Office, LLC

Family Office

Position in ABBV — AbbVie Inc.

CIK 1938970 RADNOR, PA

Position in ABBV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$14,779,320

+$1,567,238 QoQ

Shares Held

58,732

-3.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#746

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Callan Family Office, LLC holds $198,735,685 across 16 Drug Manufacturers - General names. ABBV ranks #4 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	54,722	$65,635,213
2	NVS	Novartis AG	107,922	$16,913,535
3	JNJ	Johnson & Johnson	64,905	$16,483,922
4	ABBV	AbbVie Inc. This page	58,732	$14,779,320
5	GSK	GSK plc	271,081	$14,210,066
6	MRK	Merck & Co., Inc.	107,070	$13,758,495
7	AZN	Astrazeneca PLC	69,688	$13,214,238
8	GILD	Gilead Sciences, Inc.	101,450	$12,817,193

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,779,320	58,732	-3.3%	Shares	Sole	2026-08-11
2026-03-31	$13,212,082	60,748	+4.0%	Shares	Sole	2026-05-13
2025-12-31	$13,343,359	58,398	+41.2%	Shares	Sole	2026-02-12
2025-09-30	$9,575,105	41,354	+18.2%	Shares	Sole	2025-11-04
2025-06-30	$6,496,700	35,000	+89.1%	Shares	Sole	2025-07-24
2025-03-31	$3,878,843	18,513	-12.3%	Shares	Sole	2025-05-13
2024-12-31	$3,750,358	21,105	+555.6%	Shares	Sole	2025-02-07
2024-09-30	$635,688	3,219	+3.4%	Shares	Sole	2024-10-08
2024-06-30	$533,941	3,113	+30.6%	Shares	Sole	2024-07-26
2024-03-31	$434,126	2,384	-4.6%	Shares	Sole	2024-05-09
2023-12-31	$387,115	2,498	+4.8%	Shares	Sole	2024-02-14
2023-09-30	$355,359	2,384	-22.4%	Shares	Sole	2023-11-14
2023-06-30	$414,160	3,074	-12.1%	Shares	Sole	2023-08-14
2023-03-31	$557,635	3,499	+73.9%	Shares	Sole	2023-05-12
2022-12-31	$325,159	2,012	—	Shares	Sole	2023-02-23
No filing history on record for this holder in this stock.